Point72 Hong Kong LTD Edwards Lifesciences Corp Call Options Transaction History

Point72 Hong Kong LTD

  • $1.35 Billion
  • Q3 2024

Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $181,214 - $236,038
2,200 Added 95.65%
4,500 $372,000
Q3 2022

Nov 14, 2022
BUY
$82.37 - $107.29 $181,214 - $236,038
2,200 Added 95.65%
4,500 $372,000
Q2 2022

Aug 15, 2022
SELL
$86.5 - $128.27 $285,450 - $423,291
-3,300 Reduced 58.93%
2,300 $219,000
Q4 2021

Feb 14, 2022
BUY
$106.37 - $130.68 $382,932 - $470,448
3,600 Added 180.0%
5,600 $725,000
Q3 2021

Nov 15, 2021
SELL
$102.91 - $122.75 $751,243 - $896,075
-7,300 Reduced 78.49%
2,000 $226,000
Q4 2020

Feb 16, 2021
BUY
$71.69 - $91.23 $666,717 - $848,439
9,300 New
9,300 $848,000

Others Institutions Holding EW

# of Institutions
1,351
Shares Held
455M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email